NRG Therapeutics Announces £2.68M Innovate UK Award to Develop New Medicines to Treat Parkinson's and Motor Neuron Disease

Corporate Breaking News

Home : NRG Therapeutics Announces £2.68M Innovate UK Award to Develop New Medicines to Treat Parkinson's and Motor Neuron Disease

May 30 2022	NRG Therapeutics Announces £2.68M Innovate UK Award to Develop New Medicines to Treat Parkinson's and Motor Neuron Disease
£2.68 million Biomedical Catalyst (BMC) early-stage award funded in part by Innovate UK to support development of disease-modifying medicines for debilitating chronic neurodegenerative disorders NRG has a pipeline of brain-penetrant small molecule inhibitors of the mitochondrial...


Source:https://www.prnewswire.com:443/news-releases/nrg-therapeutics-announces-2-68m-innovate-uk-award-to-develop-new-medicines-to-treat-parkinsons-and-motor-neuron-disease-301556813.html

Related News
» Ontotext Receives Growth Funding to Expand in the US, Strengthen its Leadership in the Knowledge Graph Market and Develop Industry-specific Offerings » Officials: 2 die in light aircraft crash in Central Texas